A simple brush could spot mouth cancer early in fanconi anaemia patients
NCT ID NCT07242261
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
People with Fanconi anaemia have a high risk of developing oral cancer, but standard biopsies are painful and risky due to their genetic sensitivity. This study tests a non-invasive oral brushing technique to detect early cancer cells in 115 patients aged 15 and older. If accurate, this method could allow for easier, more frequent monitoring and earlier diagnosis.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- oral brushing
- What this could lead to
- If successful, this gentle brushing method could replace painful biopsies for detecting early oral cancer in Fanconi anaemia patients, enabling earlier diagnosis.
- What could go wrong
- This is an early-stage diagnostic study, not a treatment. The brushing method may not be as accurate as a biopsy, and results need confirmation in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 115 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Oct 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
15 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * have Fanconi anaemia * are aged 15 years or older * have at least one oral lesion with or without warning signs * who agree to participate in the study Exclusion Criteria: * pregnant and breastfeeding women * protected by law (guardianship, curatorship, judicial protection) * refusing to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fanconi anaemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a daily pill boost blood counts in fanconi anemia?
- Can a single drink reveal how alcohol triggers oral cancer?
- Gene therapy aims to fix bone marrow failure in fanconi anemia
- New transplant method aims to reduce complications in bone marrow failure patients
- New MRI method could spot oral cancer early in rare disease patients
- New hope for rare cancer: targeted drug afatinib tested in fanconi anemia patients